ArticleFuture science OA2016

Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.

Satoshi Takashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.